OPB-111077 is a novel, highly specific oral signal transducer and activator of transcription 3 inhibitor that has exhibited good efficacy against solid and blood cancers, including acute myeloid leukemia (AML), in preclinical models. The gene discussed is STAT3; the disease is hematopoietic and lymphoid system neoplasm.